Jenny Permuth‐Wey

<i>BRCA1</i> and <i>BRCA2</i> mutations account for a large proportion of ovarian carcinoma cases

Tuya Pal, Jenny Permuth‐Wey, Judith A. Betts et al. · Cancer · 2005 · 691 citations

Life Sciences, Genetics, Oncology +14

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen, Karen A. Pooley, Sharon E. Johnatty et al. · Nature Genetics · 2013 · 540 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

Weicheng Kong, Lili He, Eric J. Richards et al. · Oncogene · 2013 · 428 citations · Full text

Medicine, Cancer Biology, Oncology +16

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Paul D.P. Pharoah, Ya-Yu Tsai, Susan J. Ramus et al. · Nature Genetics · 2013 · 361 citations · Full text

Life Sciences, Genetics, Oncology +14

Improved survival in BRCA2 carriers with ovarian cancer

Tuya Pal, Jenny Permuth‐Wey, Rachna Kapoor et al. · Familial Cancer · 2006 · 64 citations · Full text

Medicine, Gynecology, Oncology +12